Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Quality of life after gamma knife radiosurgery for benign lesions: a prospective study.

Autor: Thakkar, Vipul V.¹ vthakkar@sero.net, Chao, Samuel T.^2,3, Barnett, Gene H.^2,4, LeGrand, Susan⁵, Rasmussen, Peter⁴, Vogelbaum, Michael A.^2,4, Reddy, Chandana A.³, Jamison, Betty², Suh, John^2,3

Publikováno v: Journal of Radiosurgery & SBRT. 2012, Vol. 1 Issue 4, p281-286. 6p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Primary lung tumour stereotactic body radiotherapy followed by concurrent mediastinal chemoradiotherapy and adjuvant immunotherapy for locally advanced non-small-cell lung cancer: a multicentre, single-arm, phase 2 trial.

Autor: Heinzerling JH; Department of Radiation Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA; Southeast Radiation Oncology, Charlotte, NC , USA. Electronic address: john.heinzerling@atriumhealth.org., Mileham KF; Department of Hematology and Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Robinson MM; Department of Biostatistics and Data Sciences, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Symanowski JT; Department of Biostatistics and Data Sciences, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Induru RR; Department of Hematology and Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Brouse GM; Department of Hematology and Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Corso CD; Department of Radiation Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA; Southeast Radiation Oncology, Charlotte, NC , USA., Prabhu RS; Department of Radiation Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA; Southeast Radiation Oncology, Charlotte, NC , USA., Haggstrom DE; Department of Hematology and Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Moeller BJ; Department of Radiation Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA; Southeast Radiation Oncology, Charlotte, NC , USA., Bobo WE; Department of Radiation Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA; Southeast Radiation Oncology, Charlotte, NC , USA., Fasola CE; Department of Radiation Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA; Southeast Radiation Oncology, Charlotte, NC , USA., Thakkar VV; Department of Radiation Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA; Southeast Radiation Oncology, Charlotte, NC , USA., Pal SE; Department of Hematology and Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Gregory JM; Clinical Trials Office, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Norek SL; Clinical Trials Office, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Begic XJ; Clinical Trials Office, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Kesarwala AH; Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA, USA., Burri SH; Department of Radiation Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA; Southeast Radiation Oncology, Charlotte, NC , USA., Simone CB 2nd; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; New York Proton Center, New York, NY, USA.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2024 Nov 27. Date of Electronic Publication: 2024 Nov 27.